Allen R. Nissenson - 01 Jul 2026 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Reporting relationship: Director
Issuer ticker: RMTI
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2026, 09:26:20 UTC
Prior SEC filing: 21 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Megan Timmins, Attorney-in-Fact for Allen R. Nissenson

Key filing fact

Allen R. Nissenson filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 06 Jul 2026.

Key facts

This page summarizes Allen R. Nissenson's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jul 2026, 09:26.

Change

Previous filing in this sequence was filed on 21 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001441889 Primary reporting owner

Nissenson Allen

Relationship: Director
Address: C/O ROCKWELL MEDICAL, INC., 30142 WIXOM ROAD, WIXOM
Signature: /s/ Megan Timmins, Attorney-in-Fact for Allen R. Nissenson
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMTI transaction

Common Stock

Award

Transaction value
Shares: +9,633
Change %: +68%
Price: $0.000000^*
Shares after: 23,892
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.

Footnote F2

Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.